A review on the new age methodologies for early detection of Alzheimer's and Parkinson's disease

Abstract

BackgroundsNeurodegenerative diseases (NDDs) such as Alzheimer's (AD) and Parkinson's (PD) are often diagnosed late, impeding effective treatment; therefore, early detection is imperative. Modern methodologies can serve a pivotal role in fulfilling the crucial need for timely detection and intervention in this context.ObjectivesEvaluate early detection's significance and summarize key technologies (biomarkers, neuroimaging, AI/ML, genetics, digital health) for enhanced diagnostic strategies in AD and PD.MethodsThis study employs a focused descriptive review approach, encompassing analysis of peer‐reviewed articles and clinical trials from existing literature, to provide a nuanced exploration of the subject matter.FindingsThis review underscores the efficacy of non‐invasive biomarkers, biosensors and emerging promising technologies for advancing early diagnosis of AD and PD.ConclusionThe landscape of early NDD detection has been reshaped by technology, yet challenges persist, encompassing the domains of validation and ethics. A collaborative effort between medical professionals, researchers and technologists is imperative to effectively address and combat NDDs.